First peanut allergy therapy gets backing from U.S. regulators' expert advisers

A U.S. Food and Drug Administration advisory panel on Friday recommended approving the first therapy for peanut allergies, which affect over 1.6 million children in the United States, despite raising concerns about the risk of severe allergic reactions it poses to young patients.


Source: Reuters Health

Be the first to comment

Leave a Reply

Your email address will not be published.


*